These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26142084)
1. Current basis for discovery and development of aryl hydrocarbon receptor antagonists for experimental and therapeutic use in atherosclerosis. Pernomian L; da Silva CHTP Eur J Pharmacol; 2015 Oct; 764():118-123. PubMed ID: 26142084 [TBL] [Abstract][Full Text] [Related]
2. Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in Differentiating Human Osteoblast-Like Cells. Yun C; Katchko KM; Schallmo MS; Jeong S; Yun J; Chen CH; Weiner JA; Park C; George A; Stupp SI; Hsu WK; Hsu EL Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324662 [TBL] [Abstract][Full Text] [Related]
3. In vitro modulatory effects of functionalized pyrimidines and piperidine derivatives on Aryl hydrocarbon receptor (AhR) and glucocorticoid receptor (GR) activities. Yar M; Shahzadi L; Farooq A; Jalil Imran S; Cerón-Carrasco JP; den-Haan H; Kumar S; Peña-García J; Pérez-Sánchez H; Grycova A; Dvorak Z; Vrzal R Bioorg Chem; 2017 Apr; 71():285-293. PubMed ID: 28267985 [TBL] [Abstract][Full Text] [Related]
4. Selective suppression of the human aryl hydrocarbon receptor function can be mediated through binding interference at the C-terminal half of the receptor. Ren L; Thompson JD; Cheung M; Ngo K; Sung S; Leong S; Chan WK Biochem Pharmacol; 2016 May; 107():91-100. PubMed ID: 26970402 [TBL] [Abstract][Full Text] [Related]
5. Smoking-induced aggravation of experimental arthritis is dependent of aryl hydrocarbon receptor activation in Th17 cells. Talbot J; Peres RS; Pinto LG; Oliveira RDR; Lima KA; Donate PB; Silva JR; Ryffel B; Cunha TM; Alves-Filho JC; Liew FY; Louzada-Junior P; de Queiroz Cunha F Arthritis Res Ther; 2018 Jun; 20(1):119. PubMed ID: 29884199 [TBL] [Abstract][Full Text] [Related]
6. Modulation of aryl hydrocarbon receptor transactivation by carbaryl, a nonconventional ligand. Boronat S; Casado S; Navas JM; Piña B FEBS J; 2007 Jul; 274(13):3327-39. PubMed ID: 17553063 [TBL] [Abstract][Full Text] [Related]
7. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa. Rinaldi AL; Morse MA; Fields HW; Rothas DA; Pei P; Rodrigo KA; Renner RJ; Mallery SR Cancer Res; 2002 Oct; 62(19):5451-6. PubMed ID: 12359752 [TBL] [Abstract][Full Text] [Related]
8. The Aryl Hydrocarbon Receptor in Immunity: Tools and Potential. Esser C Methods Mol Biol; 2016; 1371():239-57. PubMed ID: 26530806 [TBL] [Abstract][Full Text] [Related]
10. Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids. Fukuda I; Mukai R; Kawase M; Yoshida K; Ashida H Biochem Biophys Res Commun; 2007 Aug; 359(3):822-7. PubMed ID: 17560542 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells. Juan SH; Lee JL; Ho PY; Lee YH; Lee WS Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657 [TBL] [Abstract][Full Text] [Related]
12. Characterisation of chlorinated, brominated and mixed halogenated dioxins, furans and biphenyls as potent and as partial agonists of the Aryl hydrocarbon receptor. Wall RJ; Fernandes A; Rose M; Bell DR; Mellor IR Environ Int; 2015 Mar; 76():49-56. PubMed ID: 25540854 [TBL] [Abstract][Full Text] [Related]
13. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076 [TBL] [Abstract][Full Text] [Related]
14. Aryl Hydrocarbon Receptor Repressor Methylation: A Link Between Smoking and Atherosclerosis. Cole JW; Xu H Circ Cardiovasc Genet; 2015 Oct; 8(5):640-2. PubMed ID: 26487726 [No Abstract] [Full Text] [Related]
15. Functional analysis of aryl hydrocarbon receptor nuclear translocator interactions with aryl hydrocarbon receptor in the yeast two-hybrid system. Yamaguchi Y; Kuo MT Biochem Pharmacol; 1995 Oct; 50(8):1295-302. PubMed ID: 7488247 [TBL] [Abstract][Full Text] [Related]
16. Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Henry EC; Kende AS; Rucci G; Totleben MJ; Willey JJ; Dertinger SD; Pollenz RS; Jones JP; Gasiewicz TA Mol Pharmacol; 1999 Apr; 55(4):716-25. PubMed ID: 10101030 [TBL] [Abstract][Full Text] [Related]
17. Blockade of the aryl hydrocarbon receptor pathway triggered by dioxin, polycyclic aromatic hydrocarbons and cigarette smoke by Phellinus linteus. Mukai M; Kasai A; Hiramatsu N; Hayakawa K; Okamura M; Tagawa Y; Yao J; Nakamura T; Kitamura M Biol Pharm Bull; 2008 Oct; 31(10):1888-93. PubMed ID: 18827349 [TBL] [Abstract][Full Text] [Related]
18. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Rowlands JC; McEwan IJ; Gustafsson JA Mol Pharmacol; 1996 Sep; 50(3):538-48. PubMed ID: 8794892 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor. Xue Z; Li D; Yu W; Zhang Q; Hou X; He Y; Kou X Food Funct; 2017 Apr; 8(4):1414-1437. PubMed ID: 28287659 [TBL] [Abstract][Full Text] [Related]